Company Filing History:
Years Active: 2022
Title: Inventor Profile: Chad M. Smutzer
Introduction
Chad M. Smutzer, an innovative inventor based in Rochester, MN, has made significant contributions to the field of electrical engineering through his groundbreaking patent. His work primarily focuses on systems that enhance the efficiency and effectiveness of current estimation in various devices.
Latest Patents
Chad holds a patent titled "Systems and Methods for Non-Invasive Current Estimation." This innovative technique allows for the non-invasive assessment of the current drawn by a Device Under Test (DUT). By monitoring the supply voltage to the DUT, frequency data is generated and utilized to create a current estimation model. The methodology involves simultaneously measuring first and second voltages through test probes connected to the DUT. Notably, this process occurs without the need to insert any circuit components into the DUT or remove any circuit conductors, showcasing a significant advancement in testing methodologies.
Career Highlights
Currently, Chad is employed at the Mayo Foundation for Medical Education and Research, where he continues to apply his expertise in developing cutting-edge technologies. His commitment to innovation has garnered attention within the research and medical communities, emphasizing the importance of non-invasive techniques in medical device testing.
Collaborations
Chad collaborates with esteemed colleagues, including Jonathan L. Fasig and Christopher Keith White, fostering a dynamic environment of teamwork and shared ideas. Together, they contribute to advancements in medical technologies, pushing the boundaries of what is possible in electrical engineering.
Conclusion
Chad M. Smutzer stands out as a remarkable inventor whose work in non-invasive current estimation not only represents a critical advancement in technology but also reflects the importance of innovation within the medical research field. His contributions continue to pave the way for improved methodologies and practices, ultimately benefiting both researchers and patients alike.